Table 2.
Cardiovascular Treatment Rates in INOCA Patients
| Author, Publication Year (n) | Hypertension/Angina Therapy (%) | Statin Therapy (%) |
|---|---|---|
| Maddox, 201072 (n=237 167) | 51 | 47 |
| Johnston, 201173 (n=5386) | 21–56 | 51 |
| Shaw, 201174 (n=824) | 10–20 | 32 |
| Jespersen, 201215 (n=5183) | 44 | 50 |
| Sedlak, 201275 (n=1864) | 34 | 32 |
| Sharaf, 201347 (n=567) | 2–39 | 10a/31b |
| Chow, 201576 (n=10 418) | N/A | 33.3 |
| Nielsen, 201741 (n=14 205) | 11.8–32.3 | 25–39.2 |
| Galway, 201777 (n=2642) | 18–46 | 34–59 |
Hypertension/Angina therapy includes: angiotensin‐converting enzyme inhibitor, angiotensin II receptor blocker, β‐blocker, and calcium channel blocker medication. INOCA indicates ischemia and no obstructive coronary artery disease; N/A, not applicable.
a
Normal coronary arteries.
b
Nonobstructive coronary artery disease.